Learn more

Marketing built for early-stage biotech and medtech

We work exclusively with spin-outs and start-ups across the North East of England and Scotland from first funding round to commercial traction. No generalist agencies. No retainers that outlast your runway.

The sector specialist for your region

Most marketing agencies understand start-ups. Very few understand what it means to commercialise a diagnostic device out of a Newcastle University lab, position a digital health platform for NHS Scotland procurement, or pitch a drug delivery spin-out to investors who can tell a Phase I trial from a feasibility study.

Read Marketing was built for exactly that intersection. We combine deep life sciences sector knowledge with a clear understanding of the commercial landscape in the North East of England and Scotland two regions that are producing world-class biotech and medtech innovation, but are routinely underserved by marketing agencies that default to London-centric playbooks.

Whether you’re three months out of the lab or preparing your Series A raise, we bring the strategic clarity and execution that early-stage companies need without the overhead of a full-service agency.

Marketing that fits your stage, not a template

01 – Pre-Seed – Seed – Building the foundation

You’ve protected the IP, assembled the founding team, and closed or are closing your first round. You need a credible commercial story before you’re ready to pitch investors or approach NHS innovation leads.

  • Investor narrative and pitch deck messaging
  • Brand identity and founding team positioning
  • Website that works for scientists and investors
  • LinkedIn presence built from zero
  • Conference debut strategy (attend, don’t exhibit)
  • NHS engagement and academic partnership comms

02 – Series A – Growth – Building the profile

You’ve proven the concept. Now you need market presence with the right investors, the right NHS partners, and the right commercial customers. The story needs to scale beyond the founding team.

  • Full conference and events strategy
  • PR and trade media in life sciences verticals
  • Commercial sales enablement content
  • Regional ecosystem positioning (SLIA, NE Life Sciences)
  • Series A investor communications
  • Digital demand generation for B2B pipeline

03 – Series B – Commercial – Building the market

You have a product, early customers, and a commercial team forming. Marketing now needs to accelerate a pipeline in the NHS, with private sector partners, and with international distributors or acquirers..

  • Account-based marketing for NHS and ICS targets
  • International market entry positioning
  • Clinical evidence communications strategy
  • Partnership and licensing campaign support
  • Brand architecture for multi-product portfolios
  • Acquisition readiness and due diligence narrative